Moderna and Merck released more positive three-year data Monday on their experimental vaccine, given to patients with the most deadly form of skin cancer in combination with the therapy Keytruda. Th… [+4190 chars]Read More
Moderna Merck say vaccine improved survival in patients with deadly skin cancer CNBC
